Talk:Doxpicomine

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
???	This article has not yet received a rating on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Doxpicomine.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Enantiomers of (R)-1-(1,3-dioxan-5-yl)-N,N-dimethyl-1-(pyridin-3-yl)methanamine

I was interested to understand if Doxpicomine was a racemic or chiral product. Pubchem lists:

(R)-1-(1,3-dioxan-5-yl)-N,N-dimethyl-1-(pyridin-3-yl)methanamine AS Doxpicomine while no proprietary name is assigned to the (S) enantiomer.

While I appreciate it may have no bearing, I decided to look at the optical activity of other opioids with a chiral amine linked to the benzylic carbon i.e. ciramadol, lefetamine (and derivatives) & trimebutine. In all those cases it was the (R) enantiomer that appeared to be the active.

All searches were carried out using PubChem. 2A0A:EF40:E7B:F301:6D2B:7F37:B8ED:ECEB (talk) 13:08, 4 September 2024 (UTC)[reply]

Column 10 lines 33-43 read:

In a preferred embodiment of the present invention, dl-N,N-dimethyl-o-phenyl-m-dioxane-5-methylamine is resolved to provide the analgesically active l-N,N-dimethyl-α-phenyl-m-dioxane-5-methylamine by the use of dibenzoyl-l-tartaric acid monohydrate. The re solved solid l-amine is taken up in ether and treated with gaseous hydrogen chloride to provide pure l-N,N- dimethyl-O-phenyl-m-dioxane-5-methylamine hydro chloride after recrystallization from methanol-ethyl acetate. 2A0A:EF40:E7B:F301:276F:2B6D:3CAD:2922 (talk) 08:53, 5 September 2024 (UTC)[reply]